Dr. John Affeldt, MD

NPI: 1275523375
Total Payments
$1.1M
2024 Payments
$243,378
Companies
17
Transactions
1,467
Medicare Patients
1,574
Medicare Billing
$161,288

Payment Breakdown by Category

Other$828,549 (78.8%)
Travel$133,438 (12.7%)
Consulting$59,390 (5.6%)
Food & Beverage$30,172 (2.9%)
Education$156.50 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $541,110 108 51.5%
Compensation for serving as faculty or as a speaker for a medical education program $140,689 41 13.4%
Travel and Lodging $133,438 576 12.7%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $98,300 28 9.3%
Consulting Fee $59,390 23 5.6%
Honoraria $48,450 20 4.6%
Food and Beverage $30,172 665 2.9%
Education $156.50 6 0.0%

Top Paying Companies

Company Total Records Latest Year
Mallinckrodt Hospital Products Inc. $409,101 367 $0 (2024)
Dompe US, Inc. $191,071 279 $0 (2024)
Mallinckrodt Enterprises LLC $105,956 133 $0 (2019)
Valeant Pharmaceuticals North America LLC $74,828 83 $0 (2017)
Shire North American Group Inc $64,536 142 $0 (2019)
Bausch & Lomb, a division of Bausch Health US, LLC $55,869 138 $0 (2021)
Bausch & Lomb Americas Inc. $53,003 106 $0 (2024)
Kala Pharmaceuticals, Inc. $43,127 70 $0 (2022)
SUN PHARMACEUTICAL INDUSTRIES INC. $40,007 57 $0 (2024)
EYEVANCE PHARMACEUTICALS LLC $7,073 19 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $243,378 301 Mallinckrodt Hospital Products Inc. ($127,650)
2023 $99,728 145 Mallinckrodt Hospital Products Inc. ($53,884)
2022 $179,063 199 Mallinckrodt Hospital Products Inc. ($106,492)
2021 $191,025 263 Mallinckrodt Hospital Products Inc. ($108,145)
2020 $18,897 59 Mallinckrodt Hospital Products Inc. ($12,931)
2019 $108,655 157 Mallinckrodt Enterprises LLC ($72,297)
2018 $74,827 125 Bausch & Lomb, a division of Bausch Health US, LLC ($32,608)
2017 $136,131 218 Valeant Pharmaceuticals North America LLC ($74,828)

All Payment Transactions

1,467 individual payment records from CMS Open Payments — Page 1 of 59

Date Company Product Nature Form Amount Type
12/30/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $6,800.00 General
Category: Ophthalmology
12/30/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $6,800.00 General
Category: Ophthalmology
12/17/2024 Alcon Vision LLC EYSUVIS (Drug) Food and Beverage In-kind items and services $25.92 General
Category: Ophthalmology
12/11/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $150.00 General
Category: IMMUNOLOGY
12/11/2024 Dompe US, Inc. OXERVATE (Drug) Food and Beverage In-kind items and services $22.25 General
Category: SOLUTION/ DROPS
12/10/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Travel and Lodging Cash or cash equivalent $348.34 General
Category: IMMUNOLOGY
12/10/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage Cash or cash equivalent $80.00 General
Category: IMMUNOLOGY
12/10/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage Cash or cash equivalent $30.00 General
Category: IMMUNOLOGY
12/10/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage Cash or cash equivalent $26.00 General
Category: IMMUNOLOGY
12/05/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $15.00 General
Category: Ophthalmology
12/05/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $10.50 General
Category: Ophthalmology
12/05/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $3.99 General
Category: Ophthalmology
12/04/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $85.00 General
Category: Ophthalmology
12/04/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $50.00 General
Category: Ophthalmology
12/04/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $46.50 General
Category: Ophthalmology
12/04/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $39.87 General
Category: Ophthalmology
12/04/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $25.00 General
Category: Ophthalmology
12/04/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $15.40 General
Category: Ophthalmology
12/04/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $15.20 General
Category: Ophthalmology
12/03/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $375.79 General
Category: Ophthalmology
12/03/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $329.15 General
Category: Ophthalmology
12/03/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $292.55 General
Category: Ophthalmology
12/03/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $198.20 General
Category: Ophthalmology
12/03/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $85.00 General
Category: Ophthalmology
12/03/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $50.00 General
Category: Ophthalmology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 461 757 $157,740 $41,240
2022 4 376 742 $142,700 $33,063
2021 5 386 770 $167,490 $39,200
2020 4 351 611 $197,065 $47,784
Total Patients
1,574
Total Services
2,880
Medicare Billing
$161,288
Procedure Codes
19

All Medicare Procedures & Services

19 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 270 513 $87,210 $21,066 24.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 114 134 $28,810 $9,218 32.0%
68761 Closure of tear duct opening using plug Office 2023 24 57 $25,960 $6,496 25.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 28 28 $8,960 $2,492 27.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 13 13 $4,160 $1,256 30.2%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 12 12 $2,640 $711.66 27.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 308 656 $111,520 $26,106 23.4%
68761 Closure of tear duct opening using plug Office 2022 24 42 $21,560 $4,679 21.7%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2022 32 32 $7,040 $1,370 19.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 12 12 $2,580 $908.03 35.2%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 297 626 $106,420 $26,920 25.3%
68761 Closure of tear duct opening using plug Office 2021 21 53 $24,640 $5,181 21.0%
68760 Repair duct opening Office 2021 12 33 $20,570 $4,599 22.4%
99202 New patient outpatient visit, total time 15-29 minutes Office 2021 27 27 $5,940 $1,353 22.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 29 31 $9,920 $1,148 11.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 241 485 $155,200 $38,425 24.8%
68760 Repair duct opening Office 2020 13 29 $17,545 $3,789 21.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 64 64 $13,760 $3,677 26.7%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 33 33 $10,560 $1,893 17.9%

About Dr. John Affeldt, MD

Dr. John Affeldt, MD is a Ophthalmology healthcare provider based in Loma Linda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275523375.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Affeldt, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $243,378 received in 2024. These payments were reported across 1,467 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($541,110).

As a Medicare-enrolled provider, Affeldt has provided services to 1,574 Medicare beneficiaries, totaling 2,880 services with total Medicare billing of $161,288. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Location Loma Linda, CA
  • Active Since 10/28/2005
  • Last Updated 03/06/2018
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1275523375

Products in Payments

  • ACTHAR (Biological) $515,057
  • OXERVATE (Drug) $174,030
  • XIIDRA (Drug) $65,599
  • MIEBO (Drug) $50,759
  • ZYLET (Drug) $48,648
  • Cequa (Drug) $39,988
  • EYSUVIS (Drug) $29,304
  • BESIVANCE (Drug) $22,888
  • LOTEMAX GEL (Drug) $21,682
  • INVELTYS (Drug) $13,928
  • LOTEMAX SM (Drug) $13,511
  • ALREX (Drug) $11,397
  • PROLENSA (Drug) $7,275
  • Flarex (Drug) $7,045
  • LOTEMAX (Drug) $5,321
  • Oxervate (Drug) $2,922
  • BLINK NUTRITEARS (Drug) $850.00
  • TYRVAYA (Drug) $642.82
  • RESTASIS MULTIDOSE (Drug) $266.90
  • RESTASIS (Drug) $179.33

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in Loma Linda